ADC Therapeutics: Shares Spike On Restructuring, But Safety Fears Undermine Bull Thesis

ADC Therapeutics' shares spiked on restructuring news, but safety concerns persist.

The company's clinical trial results have raised questions about the safety of its drugs.

Want to stay up to date with the world events at sea or at home?